The small GTPase adenosine diphosphate-ribosylation factor 6 (ARF6) has been shown to control cutaneous melanoma invasion via activation of both PI3K and AKT and a relationship has been found between ARF6 hyperactivation and metastasis of cancer [216]. This evidence concerns the gene ARF6 and cutaneous melanoma.